Annals of the Rheumatic Diseases




One-year access to more than 500 world journals available in the system
    http://medilib.ir
  • Duration of Time : 365 Day
  • Price : 300$
  • Special Price : 100$
Order

Ralph C Williams Jr and the world of rheumatology: a tribute from Sweden

Frank A Wollheim, G?ran Kronvall

doi : 10.1136/annrheumdis-2020-218852

(28 September, 2020)

Buy The Package and View The Article Online


Infectious complications of rheumatoid arthritis and psoriatic arthritis during targeted and biological therapies: a viewpoint in 2020

Olivier Lortholary, Mario Fernandez-Ruiz, John W Baddley, Oriol Manuel, Xavier Mariette, Kevin L Winthrop

doi : 10.1136/annrheumdis-2020-217092

(22 September, 2020)

Biological therapies have improved the outcomes of several major inflammatory, autoimmune and also neoplastic disorders. Those directed towards cytokines or other soluble mediators, cell-surface molecules or receptors or various components of intracellular signalling pathways may be associated with the occurrence of infections whose diversity depends on the particular immune target.

Buy The Package and View The Article Online


Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study

Jose L Pablos, Mar?a Galindo, Loreto Carmona, Ana Lled?, Miriam Retuerto, Ricardo Blanco, Miguel A Gonzalez-Gay, David Martinez-Lopez, Isabel Castrej?n, José M Alvaro-Gracia, David Fern?ndez Fern?ndez, Antonio Mera-Varela, Sara Manrique-Arija, Natalia Mena V?zquez, Antonio Fernandez-Nebro

doi : 10.1136/annrheumdis-2020-218296

(12 August, 2020)

Objectives The impact of inflammatory rheumatic diseases on COVID-19 severity is poorly known. Here, we compare the outcomes of a cohort of patients with rheumatic diseases with a matched control cohort to identify potential risk factors for severe illness.

Buy The Package and View The Article Online


Two-year cost effectiveness between two gradual tapering strategies in rheumatoid arthritis: cost-utility analysis of the TARA trial

Elise van Mulligen, Angelique E Weel, Tjallingius Martijn Kuijper, N H A M Denissen, Andreas H Gerards, Mike H de Jager, Wai-Kwan Lam-Tse, J M Hazes, Annette van der Helm-van Mil, Pascal Hendrik Pieter de Jong, Jolanda J Luime

doi : 10.1136/annrheumdis-2020-217528

(9 September, 2020)

Objective The aim of the current study was to evaluate the 2-year cost-utility ratio between tapering conventional synthetic disease-modifying antirheumatic drugs (csDMARD) first followed by the tumour necrosis factor (TNF)-inhibitor, or vice versa, in patients with rheumatoid arthritis (RA).

Buy The Package and View The Article Online


Circulating microbial small RNAs are altered in patients with rheumatoid arthritis

Michelle J Ormseth, Qiong Wu, Shilin Zhao, Ryan M Allen, Joseph Solus, Quanhu Sheng, Yan Guo, Fei Ye, Marisol Ramirez-Solano, S Louis Bridges, Jeffrey R Curtis, Kasey Vickers, C Michael Stein

doi : 10.1136/annrheumdis-2020-217589

(21 September, 2020)

Objectives To determine if plasma microbial small RNAs (sRNAs) are altered in patients with rheumatoid arthritis (RA) compared with control subjects, associated with RA disease-related features, and altered by disease-modifying antirheumatic drugs (DMARDs).

Buy The Package and View The Article Online


Identification of new susceptibility loci associated with rheumatoid arthritis

Rui-Xue Leng, Dong-Sheng Di, Jing Ni, Xiao-Xiao Wu, Lin-Lin Zhang, Xu-Fan Wang, Rui-Shan Liu, Qian Huang, Yin-Guang Fan, Hai-Feng Pan, Bin Wang, Dong-Qing Ye

doi : 10.1136/annrheumdis-2020-217351

(31 August, 2020)

Objectives The present study aimed to discover novel susceptibility loci associated with risk of rheumatoid arthritis (RA).

Buy The Package and View The Article Online


Genomic risk scores for juvenile idiopathic arthritis and its subtypes

Rodrigo C?novas, Joanna Cobb, Marta Brozynska, John Bowes, Yun R Li, Samantha Louise Smith, Hakon Hakonarson, Wendy Thomson, Justine A Ellis, Gad Abraham, Jane E Munro, Michael Inouye

doi : 10.1136/annrheumdis-2020-217421

(4 September, 2020)

Objectives Juvenile idiopathic arthritis (JIA) is an autoimmune disease and a common cause of chronic disability in children. Diagnosis of JIA is based purely on clinical symptoms, which can be variable, leading to diagnosis and treatment delays. Despite JIA having substantial heritability, the construction of genomic risk scores (GRSs) to aid or expedite diagnosis has not been assessed. Here, we generate GRSs for JIA and its subtypes and evaluate their performance.

Buy The Package and View The Article Online


Blood-brain barrier leakage in systemic lupus erythematosus is associated with gray matter loss and cognitive impairment

Lyna Kamintsky, Steven D Beyea, John D Fisk, Javeria A Hashmi, Antonina Omisade, Cynthia Calkin, Tim Bardouille, Chris Bowen, Maher Quraan, Arnold Mitnitski, Kara Matheson, Alon Friedman, John G Hanly

doi : 10.1136/annrheumdis-2020-218004

(1 October, 2020)

Objectives To examine the association between blood-brain barrier (BBB) integrity, brain volume and cognitive dysfunction in adult patients with systemic lupus erythematosus (SLE).

Buy The Package and View The Article Online


Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sj?gren’s syndrome with ectopic germinal centres and MALT lymphoma

Elena Pontarini, William James Murray-Brown, Cristina Croia, Davide Lucchesi, James Conway, Felice Rivellese, Liliane Fossati-Jimack, Elisa Astorri, Edoardo Prediletto, Elisa Corsiero, Francesca Romana Delvecchio, Rachel Coleby, Eva Gelbhardt, Aurora Bono, Chiara Baldini, Ilaria Puxeddu, Piero Ruscitti, Roberto Giacomelli, Francesca Barone, Benjamin Fisher, Simon J Bowman, Serena Colafrancesco, Roberta Priori, Nurhan Sutcliffe, Stephen Challacombe, Gianluca Carlesso, Anwar Tappuni, Costantino Pitzalis, Michele Bombardieri

doi : 10.1136/annrheumdis-2020-217646

(22 September, 2020)

Objectives To explore the relevance of T-follicular-helper (Tfh) and pathogenic peripheral-helper T-cells (Tph) in promoting ectopic lymphoid structures (ELS) and B-cell mucosa-associated lymphoid tissue (MALT) lymphomas (MALT-L) in Sj?gren’s syndrome (SS) patients.

Buy The Package and View The Article Online


A randomised, double-blind, placebo-controlled, 24-week, phase II, proof-of-concept study of romilkimab (SAR156597) in early diffuse cutaneous systemic sclerosis

Yannick Allanore, Peter Wung, Christina Soubrane, Corinne Esperet, Frederic Marrache, Raphael Bejuit, Amel Lahmar, Dinesh Khanna, Christopher P Denton

doi : 10.1136/annrheumdis-2020-218447

(22 September, 2020)

Objectives Recent advances in systemic sclerosis (SSc) show that it involves a T-helper type-2-oriented immune response with interleukin (IL)-4 and IL-13. Romilkimab is an engineered, humanised, bispecific immunoglobulin-G4 antibody that binds and neutralises IL-4/IL-13 making it ideal for exploration in fibrosis.

Buy The Package and View The Article Online


Machine learning predicts stem cell transplant response in severe scleroderma

Jennifer M Franks, Viktor Martyanov, Yue Wang, Tammara A Wood, Ashley Pinckney, Leslie J Crofford, Lynette Keyes-Elstein, Daniel E Furst, Ellen Goldmuntz, Maureen D Mayes, Peter McSweeney, Richard A Nash, Keith M Sullivan, Michael L Whitfield

doi : 10.1136/annrheumdis-2020-217033

(15 September, 2020)

Objective The Scleroderma: Cyclophosphamide or Transplantation (SCOT) trial demonstrated clinical benefit of haematopoietic stem cell transplant (HSCT) compared with cyclophosphamide (CYC). We mapped PBC (peripheral blood cell) samples from the SCOT clinical trial to scleroderma intrinsic subsets and tested the hypothesis that they predict long-term response to HSCT.

Buy The Package and View The Article Online


Risk of venous thromboembolism in knee, hip and hand osteoarthritis: a general population-based cohort study

Chao Zeng, Kim Bennell, Zidan Yang, Uyen-Sa D T Nguyen, Na Lu, Jie Wei, Guanghua Lei, Yuqing Zhang

doi : 10.1136/annrheumdis-2020-217782

(16 September, 2020)

Objectives Osteoarthritis is a leading cause of immobility and joint replacement, two strong risk factors for venous thromboembolism (VTE). We aimed to examine the relation of knee, hip and hand osteoarthritis to the risk of VTE and investigate joint replacement as a potential mediator.

Buy The Package and View The Article Online


Identification of the skeletal progenitor cells forming osteophytes in osteoarthritis

Anke J Roelofs, Karolina Kania, Alexandra J Rafipay, Meike Sambale, Stephanie T Kuwahara, Fraser L Collins, Joanna Smeeton, Maxwell A Serowoky, Lynn Rowley, Hui Wang, René Gronewold, Chrysa Kapeni, Sim?n Méndez-Ferrer, Christopher B Little, John F Bateman, Thomas Pap, Francesca V Mariani, Joanna Sherwood, J Gage Crump, Cosimo De Bari

doi : 10.1136/annrheumdis-2020-218350

(22 September, 2020)

Objectives Osteophytes are highly prevalent in osteoarthritis (OA) and are associated with pain and functional disability. These pathological outgrowths of cartilage and bone typically form at the junction of articular cartilage, periosteum and synovium. The aim of this study was to identify the cells forming osteophytes in OA.

Buy The Package and View The Article Online


TRIM24-RIP3 axis perturbation accelerates osteoarthritis pathogenesis

Jimin Jeon, Hyun-Jin Noh, Hyemi Lee, Han-Hee Park, Yu-Jin Ha, Seok Hee Park, Haeseung Lee, Seok-Jung Kim, Ho Chul Kang, Seong-il Eyun, Siyoung Yang, You-Sun Kim

doi : 10.1136/annrheumdis-2020-217904

(7 September, 2020)

Objectives Recently, necroptosis has attracted increasing attention in arthritis research; however, it remains unclear whether its regulation is involved in osteoarthritis (OA) pathogenesis. Since receptor-interacting protein kinase-3 (RIP3) plays a pivotal role in necroptosis and its dysregulation is involved in various pathological processes, we investigated the role of the RIP3 axis in OA pathogenesis.

Buy The Package and View The Article Online


Activation of acid-sensing ion channel 3 by lysophosphatidylcholine 16:0 mediates psychological stress-induced fibromyalgia-like pain

Chih-Hsien Hung, Cheng-Han Lee, Ming-Hsien Tsai, Chu-Huang Chen, Hsiu-Fen Lin, Chung-Yao Hsu, Chiou-Lian Lai, Chih-Cheng Chen

doi : 10.1136/annrheumdis-2020-218329

(9 September, 2020)

Objectives Fibromyalgia is commonly considered a stress-related chronic pain disorder, and daily stressors are known triggers. However, the relation between stress and pain development remains poorly defined by clinical approaches. Also, the aetiology remains largely unknown.

Buy The Package and View The Article Online


Impact of delayed diagnoses at the time of COVID-19: increased rate of preventable bilateral blindness in giant cell arteritis

Sara Monti, Paolo Delvino, Elisa Bellis, Alessandra Milanesi, Fabio Brandolino, Carlomaurizio Montecucco

doi : 10.1136/annrheumdis-2020-217915

(24 May, 2020)

Buy The Package and View The Article Online


Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseases

Laura Nu?o, Marta Novella Navarro, Gema Bonilla, Karen Franco-G?mez, Pilar Aguado, Diana Peiteado, Irene Monjo, Carolina Tornero, Alejandro Villalba, Maria-Eugenia Miranda-Carus, Eugenio De Miguel, Patricia Bogas, Ana Castilla-Plaza, Miguel Bernad-Pineda, Elena Garc?a-Lorenzo, Tamara Rodr?guez-Araya, Alejandro Balsa

doi : 10.1136/annrheumdis-2020-218054

(30 June, 2020)

Buy The Package and View The Article Online


Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19

Panayiotis G Vlachoyiannopoulos, Eleni Magira, Haris Alexopoulos, Edison Jahaj, Katerina Theophilopoulou, Anastasia Kotanidou, Athanasios G Tzioufas

doi : 10.1136/annrheumdis-2020-218009

(24 June, 2020)

Buy The Package and View The Article Online


Biologics, spondylitis and COVID-19

James Todd Rosenbaum, Hedley Hamilton, Dongseok Choi, Michael H Weisman, John D Reveille, Kevin L Winthrop

doi : 10.1136/annrheumdis-2020-217941

(10 June, 2020)

Buy The Package and View The Article Online


Pneumonia vaccination timing in relation to starting conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis

Ruth E Costello, Jenny H Humphreys, Kevin L Winthrop, William G Dixon

doi : 10.1136/annrheumdis-2020-217255

(26 June, 2020)

Buy The Package and View The Article Online


On using machine learning algorithms to define clinically meaningful patient subgroups

Rachel Knevel, Tom WJ Huizinga

doi : 10.1136/annrheumdis-2019-215959

(11 July, 2019)

Buy The Package and View The Article Online


Response to: ‘On using machine learning algorithms to define clinically meaningful patient subgroups’ by Knevel and Huizinga

Alain Meyer, Lionel Spielmann, François Séverac

doi : 10.1136/annrheumdis-2019-215989

(17 August, 2019)

Buy The Package and View The Article Online


Association between proton pump inhibitors therapy and fracture risk in patients with rheumatoid arthritis

Shih-Wei Lai, Yu-Hung Kuo, Kuan-Fu Liao

doi : 10.1136/annrheumdis-2019-215982

(12 July, 2019)

Buy The Package and View The Article Online


Response to: ‘Association between proton pump inhibitors therapy and fracture risk in patients with rheumatoid arthritis’ by Lai et al

Gulsen Ozen, Kaleb Michaud

doi : 10.1136/annrheumdis-2019-215992

(12 August, 2019)

Buy The Package and View The Article Online


Performance of the systemic lupus erythematosus disease activity score (SLE-DAS) in a Latin American population.

Melissa G Rodr?guez-Gonz?lez, Grissell A Valero-Gaona, Tania Vargas-Aguirre, Luis M Amezcua Guerra

doi : 10.1136/annrheumdis-2019-216028

(29 July, 2019)

Buy The Package and View The Article Online


Response to: ‘Performance of the systemic lupus erythematosus disease activity score (SLE-DAS) in a Latin American population’ by Rodr?guez-Gonz?lez et al

Diogo Jesus, Ana Matos, Carla Henriques, Margherita Zen, Andrea Doria, Lu?s Sousa Inês

doi : 10.1136/annrheumdis-2019-216110

(7 August, 2019)

Buy The Package and View The Article Online


Ultrasonographic salivary gland evaluation in systemic sclerosis: is sicca syndrome secondary to an authentic overlap syndrome or another specific fibrotic manifestation of the disease?

Guillaume Coiffier, Sandrine Jousse-Joulin, Divi Cornec, Ronan Garlantézec, Aurore Bleuzen, Elisabeth Diot, Patrick Jego, Alice Ballerie, Alain Lescoat

doi : 10.1136/annrheumdis-2019-215972

(12 July, 2019)

Buy The Package and View The Article Online


Response to: ‘Ultrasonographic salivary gland evaluation in systemic sclerosis: is sicca syndrome secondary to an authentic overlap syndrome or another specific fibrotic manifestation of the disease?’ by Coiffier et al

Marion Couderc, Jean-Jacques Dubost

doi : 10.1136/annrheumdis-2019-215991

(7 August, 2019)

Buy The Package and View The Article Online


ugmented versus artificial intelligence for stratification of patients with myositis

Michael Mahler, Brenden Rossin, Olga Kubassova

doi : 10.1136/annrheumdis-2019-216000

(30 July, 2019)

Buy The Package and View The Article Online


Response to ‘Augmented vs. artificial intelligence for stratification of patients with myositis’ by Mahler et al

Alain Meyer, Lionel Spielmann, François Séverac

doi : 10.1136/annrheumdis-2019-216014

(30 July, 2019)

Buy The Package and View The Article Online


How to communicate in science

Lars Klareskog, Anca Irinel Catrina, Camilla Svensson, Vivianne Malmstrom

doi : 10.1136/annrheumdis-2019-216016

(13 August, 2019)

Buy The Package and View The Article Online


Response to: “How to communicate in science” by Klareskog et al

René Toes, David S Pisetsky

doi : 10.1136/annrheumdis-2019-216045

(13 August, 2019)

Buy The Package and View The Article Online


Effectiveness of influenza vaccine in TNF inhibitors treated patients: comment on the article by Burmester et al

Giovanni Adami, Angelo Fassio, Giovanni Orsolini, Alessandro Giollo, Davide Gatti, Maurizio Rossini

doi : 10.1136/annrheumdis-2019-215174

(20 February, 2019)

Buy The Package and View The Article Online


Is retinal microvascular damage an early manifestation of systemic sclerosis?

Florenzo Iannone, Cinzia Rotondo

doi : 10.1136/annrheumdis-2019-215127

(9 February, 2019)

Buy The Package and View The Article Online


Do you want to add Medilib to your home screen?